Huang, Yifan
AstraZeneca (United States)
3 papers on CoChatORCID 0000-0003-1060-3668
Most cited papers
- Verified
Durvalumab after chemoradiotherapy in stage III non–small-cell lung cancer
Antonia, S. J., Villegas, A., Daniel, D., Vicente, D., Murakami, S., Hui, R., Yokoi, T., Chiappori, A., Lee, K. H., de Wit, M., et al. (2017) · New England Journal of Medicine
Cancer Immunotherapy and BiomarkersLung Cancer Diagnosis and Treatment
Cited by 4,593
- Verified
Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study
Garassino, M. C., Cho, B.-C., Kim, J.-H., Mazières, J., Vansteenkiste, J., Lena, H., Corral Jaime, J., Gray, J. E., Powderly, J., Chouaid, C., et al. (2018) · The Lancet Oncology
Cancer Immunotherapy and BiomarkersLung Cancer Treatments and Mutations
Cited by 568
- Verified
Maternal Vitamin D Deficiency during Pregnancy Results in Insulin Resistance in Rat Offspring, Which Is Associated with Inflammation and Iκbα Methylation
Zhang, H., Chu, X., Huang, Y., Li, G., Wang, Y., Li, Y., & Sun, C. (2014) · Diabetologia
Birth, Development, and HealthVitamin D Research Studies
Cited by 60
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free